Improve hand dexterity with imagery

Trial ID
NCT07193303
Official Title
The Immediate Effect of Mental Imagery on Upper Extremity Skills With the Patients of Parkinson's Disease
Goal
Improve hand dexterity with imagery
Phase
NA
Status
RECRUITING
Sponsor
Kahramanmaras Sutcu Imam University
Study Type
INTERVENTIONAL
Enrollment
30 participants
Conditions
PARKINSON DISEASE (Disorder), Mental Imagery, Motor Imagery
Interventions
mental imagination

Plain-Language Summary

The goal is to find out whether guided mental imagery can produce immediate improvements in hand and arm skills that people with Parkinson's use for everyday tasks. The approach asks participants to mentally rehearse specific upper‑limb movements, which activates motor planning networks in the brain and can prime better movement execution without physical practice, and it is noninvasive so it can be used alongside usual medications like levodopa. Effects are measured right after the mental imagery on standard dexterity and motor tasks to see if there is a quick benefit. The trial is looking for people aged 40 to 75 with idiopathic Parkinson's, Hoehn and Yahr stage 4 or lower, adequate cognition (MMSE ≥24 for those receiving training, ≥18 for those not), no other neurologic or systemic disease, and no upper extremity contractures; people on neuroleptics or antidepressants, with treated psychiatric illness, or with orthopedic/other neurologic problems affecting the hands are excluded.

Locations

  • Kahramanmaraş Sütçü imam University, Kahramanmaraş, Onikişubat, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying mental imagination. The goal is to find out whether guided mental imagery can produce immediate improvements in hand and arm skills that people with Parkinson's use for everyday tasks. The approach asks participants to mentally rehearse specific upper‑limb movements, which activates motor planning networks in the brain and can prime better movement execution without physical practice, and it is noninvasive so it can be used alongside usual medications like levodopa. Effects are measured right after the mental imagery on standard dexterity and motor tasks to see if there is a quick benefit. The trial is looking for people aged 40 to 75 with idiopathic Parkinson's, Hoehn and Yahr stage 4 or lower, adequate cognition (MMSE ≥24 for those receiving training, ≥18 for those not), no other neurologic or systemic disease, and no upper extremity contractures; people on neuroleptics or antidepressants, with treated psychiatric illness, or with orthopedic/other neurologic problems affecting the hands are excluded.
Who can participate?
Participants must be between 40 Years and 75 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 6 months.

View on ClinicalTrials.gov